Nuvaxovid vaccine (Novavax) is included in the program vaccination anti-Covid currently only for the primary cycletogether with vaccines already authorized for use in the European Union. Nuvaxovid it is administered intramuscularly (preferably in the deltoid region of the arm) as a cycle of two doses (0.5 mL each) at a distance of three weeks (21 days) from each other. These are the provisions contained in the circular of Ministry of Health ‘Indication for use of the Nuvaxovid (Novavax) COVID-19 vaccine in subjects aged 18 years‘, signed by the Director of Prevention of the ministry Gianni Rezza.
On December 22, it is emphasized in the circular of the ministry, the Technical Scientific Commission of Aifaaccepting the opinion expressed by the European Medicines Agency (Mom), approved the indication of use of the Nuvaxovid vaccinein the specific formulation for injection from 0.5mL/dosestarting with 18 years of age. Each Nuvaxovid multidose vial is equal to 10 doses 0.5 mL, requires no dilution and therefore it is ready to use. The unopened vial, stored in the refrigerator at a temperature including between 2 ° C and 8 ° Chas a validity of 9 months. The closed vial, a room temperature up to 25 ° C, it can be used within 12 hours. After the first perforation, the vial can be stored at a temperature between 2 ° C and 25 ° C and is usable within 6 hours.
Support ilfattoquotidiano.it: never as in this moment do we need you
In these difficult and extraordinary times, it is essential to guarantee quality information. For us at ilfattoquotidiano.it the only masters are the readers. Unlike others, we want to offer journalism that is open to all, without paywalls. Your contribution is essential to allow us to do this. Become a supporter too
Thank you,
Peter Gomez
Support now
Previous article
Coronavirus, the data – Over 60 thousand infections in 24 hours: the positivity rate drops to 9.9%. Another 322 victims
